drugset / Trial / NCT01827540
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Non-randomizedCrossoverOpen-label
Summary
To evaluate the PK, safety and tolerability of Cenicriviroc (CVC) administered with and without Dolutegravir (DTG) and CVC with and without a single dose of Midazolam in healthy subjects.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cenicriviroc | Small molecule | 150 mg | Oral |
| Subject | Dolutegravir | Other / unclassified | 50 mg | — |
| Subject | Midazolam | Small molecule | 5 mg | Oral |